Assembly Biosciences ASMB Return on equity

Return on equity at other companies

Arrowhead ResearchARWR

-46.4%+341pp

ALN

Alnylam PharmaceuticalsALNY

91.4%—

Avalo TherapeuticsAVTX

-36.3%—

Arbutus Biopharma CorporationABUS

94.7%+65.1pp

Vir Biotechnology, Inc.VIR

-26.1%-7.9pp

Absci CorporationABSI

-57.7%+0.3pp

FAQ

What is Assembly Biosciences's return on equity?

Assembly Biosciences (ASMB) reported return on equity of -36.9% in Q3 2025.

How has Assembly Biosciences's return on equity changed year-over-year?

Assembly Biosciences's return on equity increased by 69.3% year-over-year, from -120.5% to -36.9%.

What is the long-term trend for Assembly Biosciences's return on equity?

Over 4 years (2020 to 2024), Assembly Biosciences's return on equity has grown at a 45.3% compound annual growth rate (CAGR), from -24.2% to -107.9%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.